Smart 532™ is the newest photocoagulator by Lumenis, enhanced with SmartPulse™ sub-threshold technology.
SLT for Glaucoma
We invite you to learn about the eye disease and the importance of regular eye exams, proper diagnosis, and appropriate treatment options in managing glaucoma and preserving vision.
Lumenis Features Acoustics & Heat Experience and Introduces PicoFractional™ Technology at the American Academy of Dermatology Annual Meeting (AAD)
Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, is thrilled to unveil Pico Fractional™, a new photoacoustic fractional laser, at the American Academy of Dermatology (AAD) Annual Meeting in San Diego, CA from February 16th-18th, 2018.
Lumenis Exhibits Innovative Energy-based Technologies and the Launch of PiQo4 at 37th Annual Conference of the American Society for Laser Medicine and Surgery
Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, proudly announces its newest launch, PiQo4 – the most powerful advanced laser technology for tattoo removal and pigmentation. The technology will be showcased at the 37th annual American Society for Laser Medicine and Surgery (ASLMS) conference in San Diego, CA from April 5th – 9th, 2017.
Lumenis is Proud to Support the First International Scar Treatment Conference in Israel
Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will be supporting the first International Scar Treatment Conference in Israel, which will be held in Tel Aviv, on February 22nd, 2017.
Lumenis to Be Acquired for Approximately $510 Million, $14.00 per Share, in Cash
Lumenis Ltd. (NASDAQ: LMNS), the world’s largest energy-based medical company for surgical, ophthalmology and aesthetic applications, announced today that it has signed a definitive agreement to be acquired by XIO Group for $14.00 per share in cash, for an aggregate purchase price of approximately $510 million.
BLEND X® Alex YAG
Binary laser emission of Nd:YAG (1064nm) and Alexandrite (755nm) wavelengths
Lumenis Introduces a New Skin Rejuvenating Technology, Legend Pro+™, at the 17th Aesthetic & Anti-Aging Medicine World Congress
HRH The Duke of Sussex visits The Queen Elizabeth Hospital in Birmingham Scar Center
Candela and Lumenis Announce Settlement of Patent Infringement Lawsuit
Candela and Lumenis Announce Settlement of Patent Infringement Lawsuit
Baring Private Equity Asia Agrees to Acquire Lumenis
Baring Private Equity Asia Agrees to Acquire Lumenis